Inventor · disambiguated record
Henning Boettcher
Also filed as: BOETTCHER HENNING
13 granted patents·7 pending applications·117 citations·filing 1992–2011
91Inventor score
Top patents by PatentIndex Score
20 records- 0187US7642261B2Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable saltsMERCK PATENT GMBH·Filed 2007·Granted Jan 5, 2010·10 cites·22 claims
- 0287US6838461B1N-(indolcarbonyl-)piperazine derivativesMERCK PATENT GMBH·Filed 2000·Granted Jan 4, 2005·23 cites·68 claims
- 0379US6900212B1Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable saltsMERCK PATENT GMBH·Filed 2000·Granted May 31, 2005·10 cites·14 claims
- 0472US7244846B2Substituted benzofuran-2-carboxamides derivativesMERCK PATENT GMBH·Filed 2002·Granted Jul 17, 2007·6 cites·19 claims
- 0571US7084143B2N-(indolecarbonyl) piperazine derivativesMERCK PATENT GMBH·Filed 2004·Granted Aug 1, 2006·4 cites·27 claims
- 0670US5242925APiperazinylbenzodioxane derivativesMERCK PATENT GMBH·Filed 1992·Granted Sep 7, 1993·23 cites·16 claims
- 0769US6960599B2Heterocyclic aminoalkylpyridine derivatives as psychopharmaceuticalsMERCK PATENT GMBH·Filed 2001·Granted Nov 1, 2005·4 cites·17 claims
- 0869US6509340B1Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT1B/1D ligandsMERCK PATENT GMBH·Filed 1998·Granted Jan 21, 2003·30 cites·10 claims
- 0966US7329749B2Piperazinylcarbonylquinolines and -isoquinolinesMERCK PATENT GMBH·Filed 2001·Granted Feb 12, 2008·3 cites·16 claims
- 1065US6762300B2Method for producing 5-(1-piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed aminationMERCK PATENT GMBH·Filed 2000·Granted Jul 13, 2004·4 cites·16 claims
- 1165US2010063062A1Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable saltsBARTOSZYK GERD·Filed 2009·Application pending·0 cites
- 1258US7371756B2Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable saltsMERCK PATENT GMBH·Filed 2004·Granted May 13, 2008·0 cites·16 claims
- 1348US2008027140A1Combinations of Serotonin Reuptake Inhibitors and Imidazoline I 2 AgonistsMERCK PATENT GMBH·Filed 2004·Application pending·0 cites
- 1446US2005176730A1Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT 1B/1D ligandsMERCK PATENT GMBH·Filed 2003·Application pending·0 cites
- 1544US7834032B2Piperidine derivativesMERCK PATENT GMBH·Filed 2005·Granted Nov 16, 2010·0 cites·20 claims
- 1644US2003064995A1Amide and urea derivatives as 5-HT reuptake inhibitors and as5-HT1B/1D ligandsMERCK PATENT GMBH·Filed 2002·Application pending·0 cites
- 1743US7312342B2Process for the preparation of (3-cyano-1h-indol-7-yl) (4-(4-fluorophenethyl) piperazin-1-yl)-methanone and salts thereofMERCK PATENT GMBH·Filed 2001·Granted Dec 25, 2007·0 cites·26 claims
- 1842US2005026927A1Pyrazole derivatives as psychopharmaceuticalsFiled 2002·Application pending·0 cites
- 1938US2003130287A1Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonistsFiled 2001·Application pending·0 cites
- 2036US2012077825A1Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable saltsBARTOSZYK GERD·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Henning Boettcher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →